Fundz

Hexagon Bio Inc. reported raising $61 Million in an initial SEC Form D filing

PRIVATEJul 19, 2021

Amount Raised

$61 Million

$61 Million sold, per SEC Form D (first sale Jul 19, 2021)

Round Type

Venture

Menlo ParkBiotechnology

Quick answer

Hexagon Bio Inc. raised $61 Million in a funding round, dated July 19, 2021. Hexagon Bio Inc. is based in Menlo Park, California, United States.

How much did Hexagon Bio Inc. raise?
Hexagon Bio Inc. raised $61 Million in a funding round on July 19, 2021.
What does Hexagon Bio Inc. do?
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics.
Where is Hexagon Bio Inc. based and how big is it?
Hexagon Bio Inc. is based in Menlo Park, California, United States. Fundz records about 65 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Hexagon Bio Inc. that raised within 45 days of this round, from Fundz verified event records.

  • GeneCapture raised $1.2M (Seed) on September 2, 2021.
  • Litmaps raised $125K (Seed) on September 2, 2021.
  • Plantible Foods Inc. raised $22M (Funding Round) on September 2, 2021.
  • Disc raised $90M (Series B) on September 2, 2021.
  • Laplace Interventional raised an undisclosed amount (Series A) on September 2, 2021.
  • Pirouette Medical raised $7M on September 2, 2021.

Who to call at Hexagon Bio Inc., and when

A new round usually means Hexagon Bio Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hexagon Bio Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hexagon Bio Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hexagon Bio Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hexagon Bio Inc.

Location

1490 O'BRIEN DRIVE

Menlo Park, California, United States

About

Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, chemistry and automation to discover potent, evolutionarily-refined small molecules and their cognate targets directly from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hexagon Bio Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Hexagon Bio Inc.'s next move

See what Strategic adds

Hexagon Bio Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.